• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

能否将 Toll 样受体 2(TLR2)视为针对乙型肝炎感染的免疫治疗的新靶点?

Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?

机构信息

Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.

出版信息

Hum Immunol. 2014 Jun;75(6):549-54. doi: 10.1016/j.humimm.2014.02.018. Epub 2014 Feb 12.

DOI:10.1016/j.humimm.2014.02.018
PMID:24530748
Abstract

The current literature describes pivotal mechanisms in which hepatitis B virus (HBV) induces liver diseases including inflammation, cirrhosis and hepatocellular carcinoma (HCC). It appears that differences in genetic and immunological parameters between patients and controls may be responsible for inducing the prolonged forms of the infection. Previous studies demonstrated that Toll-Like Receptors (TLRs) play key roles in viral recognition and inducing appropriate immune responses. Therefore, TLRs can be considered as key sensors for HBV recognition and subsequent induction of immune responses against this virus. It has also been shown that the TLR2 detects several microbial PAMPs either in its homodimer form or in a heterodimer with TLR1 or TLR6 and subsequently activates NF-κB in a MYD88 dependent manner. Therefore, defective TLR2 expression may result in impaired immune responses against HBV which is reported in long-term forms of hepatitis B. This review presents the recent data regarding the status and important roles played by TLR2 in HBV recognition and induction or suppression of immune responses against HBV as well as its roles in the pathogenesis of cirrhosis and HCC in prolonged hepatitis B forms.

摘要

目前的文献描述了乙型肝炎病毒 (HBV) 引发肝脏疾病的关键机制,包括炎症、肝硬化和肝细胞癌 (HCC)。似乎患者和对照组之间遗传和免疫参数的差异可能导致感染的持续形式。先前的研究表明,Toll 样受体 (TLR) 在病毒识别和诱导适当免疫反应中发挥关键作用。因此,TLR 可以被视为 HBV 识别和随后诱导针对该病毒的免疫反应的关键传感器。也已经表明,TLR2 以 MYD88 依赖性方式检测其同源二聚体形式或与 TLR1 或 TLR6 形成的异源二聚体中的几种微生物 PAMP,并随后激活 NF-κB。因此,TLR2 表达缺陷可能导致针对 HBV 的免疫反应受损,这在乙型肝炎的长期形式中已有报道。这篇综述介绍了关于 TLR2 在 HBV 识别以及诱导或抑制针对 HBV 的免疫反应中的地位和重要作用的最新数据,以及其在慢性乙型肝炎形式的肝硬化和 HCC 发病机制中的作用。

相似文献

1
Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?能否将 Toll 样受体 2(TLR2)视为针对乙型肝炎感染的免疫治疗的新靶点?
Hum Immunol. 2014 Jun;75(6):549-54. doi: 10.1016/j.humimm.2014.02.018. Epub 2014 Feb 12.
2
Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.慢性乙型肝炎患者外周血单个核细胞中Toll样受体2和4的表达谱及功能
Clin Immunol. 2008 Sep;128(3):400-8. doi: 10.1016/j.clim.2008.04.006. Epub 2008 Jun 20.
3
Association of mRNA expression of toll-like receptor 2 and 3 with hepatitis B viral load in chronic hepatitis, cirrhosis, and hepatocellular carcinoma.Toll 样受体 2 和 3 的 mRNA 表达与慢性肝炎、肝硬化和肝细胞癌中乙型肝炎病毒载量的关系。
J Med Virol. 2017 Jun;89(6):1008-1014. doi: 10.1002/jmv.24719. Epub 2017 Jan 10.
4
NK cells in hepatitis B virus infection: a potent target for immunotherapy.乙型肝炎病毒感染中的自然杀伤细胞:免疫治疗的有效靶点。
Arch Virol. 2014 Jul;159(7):1555-65. doi: 10.1007/s00705-013-1965-3. Epub 2014 Jan 21.
5
TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome.TLR2 作为一种病原体识别受体,在乙型肝炎的结局中发挥关键作用。
Viral Immunol. 2022 Jan-Feb;35(1):15-23. doi: 10.1089/vim.2021.0141. Epub 2022 Jan 11.
6
Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.乙型肝炎病毒 X 蛋白通过 MyD88 依赖途径刺激肝细胞中白细胞介素 6 的表达。
J Hepatol. 2011 Jan;54(1):26-33. doi: 10.1016/j.jhep.2010.08.006. Epub 2010 Sep 6.
7
Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.树突状细胞中Toll样受体2/4的表达与慢性乙型肝炎病毒感染之间的关系
Int J Clin Exp Pathol. 2014 Aug 15;7(9):6048-55. eCollection 2014.
8
The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.肝细胞癌的发病机制是一个多因素事件。新型免疫治疗前景可期。
Clin Ter. 2004 May;155(5):187-99.
9
Correlation of circulating TLR2/4 expression with CD3+/4+/8+ T cells and Treg cells in HBV-related liver cirrhosis.循环中TLR2/4表达与HBV相关肝硬化中CD3+/4+/8+ T细胞及调节性T细胞的相关性
Viral Immunol. 2009 Oct;22(5):301-8. doi: 10.1089/vim.2009.0039.
10
Toll-like receptor 4 and hepatitis B infection: molecular mechanisms and pathogenesis.Toll样受体4与乙型肝炎感染:分子机制与发病机制
Viral Immunol. 2014 Sep;27(7):321-6. doi: 10.1089/vim.2014.0039. Epub 2014 Jul 11.

引用本文的文献

1
inhibits the TNF-α-induced increase in intestinal epithelial tight junction permeability via a TLR-2 and PI3K-dependent inhibition of NF-κB activation.通过 TLR-2 和 PI3K 依赖性抑制 NF-κB 激活,抑制 TNF-α 诱导的肠道上皮紧密连接通透性增加。
Front Immunol. 2024 Jul 16;15:1348010. doi: 10.3389/fimmu.2024.1348010. eCollection 2024.
2
Evaluation of Immunomodulatory Activity of Lipopolysaccharide Zinc Oxide Nanoparticles (LPS-ZnNPS).评价脂多糖氧化锌纳米粒子(LPS-ZnNPS)的免疫调节活性。
Arch Razi Inst. 2022 Oct 31;77(5):1821-1829. doi: 10.22092/ARI.2022.358493.2233. eCollection 2022 Oct.
3
Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection.
新型分子治疗药物靶向信号通路控制乙型肝炎病毒感染。
Front Cell Infect Microbiol. 2022 Feb 18;12:847539. doi: 10.3389/fcimb.2022.847539. eCollection 2022.
4
Differential Expression of the Gene in Pan-Cancer and Its Related Mechanism.该基因在泛癌中的差异表达及其相关机制。
Front Cell Dev Biol. 2021 Sep 23;9:700661. doi: 10.3389/fcell.2021.700661. eCollection 2021.
5
Crosstalk network among multiple inflammatory mediators in liver fibrosis.多种炎症介质在肝纤维化中的串扰网络。
World J Gastroenterol. 2019 Sep 7;25(33):4835-4849. doi: 10.3748/wjg.v25.i33.4835.
6
Up-regulation of RIP1 and IPS-1 in chronic HBV infected patients.慢性乙肝感染患者中RIP1和IPS-1的上调。
Genet Mol Biol. 2019 Apr-Jun;42(2):337-343. doi: 10.1590/1678-4685-GMB-2018-0071. Epub 2019 Aug 19.
7
Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review.炎性小体及其在病毒性肝炎发病机制及相关并发症中的作用:更新的系统评价。
Immunol Lett. 2019 Apr;208:11-18. doi: 10.1016/j.imlet.2019.03.001. Epub 2019 Mar 1.
8
Pyroptosis of MCF7 Cells Induced by the Secreted Factors of hUCMSCs.人脐带间充质干细胞分泌因子诱导MCF7细胞焦亡
Stem Cells Int. 2018 Nov 11;2018:5912194. doi: 10.1155/2018/5912194. eCollection 2018.
9
TLR2 Expression in Peripheral CD4+ T Cells Promotes Th17 Response and Is Associated with Disease Aggravation of Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.外周血CD4+ T细胞中TLR2的表达促进Th17反应并与乙型肝炎病毒相关慢加急性肝衰竭的疾病加重相关。
Front Immunol. 2017 Nov 23;8:1609. doi: 10.3389/fimmu.2017.01609. eCollection 2017.
10
Variants in the non-coding region of the TLR2 gene associated with infectious subphenotypes in pediatric sickle cell anemia.TLR2 基因非编码区变异与儿童镰状细胞贫血感染亚表型相关。
Immunogenetics. 2018 Jan;70(1):37-51. doi: 10.1007/s00251-017-1013-7. Epub 2017 Jun 30.